Register
Community
Physicians
Editors
Experts
Code of conduct
Blog
Company
About
Publications
Press
Careers
Programs
Journal Club
Targeted Topic
Clinical Trial
Tumor Board
Contact Us
Sign in
Topics:
Genitourinary Cancers
•
Pediatric Oncology
•
Medical Oncology
•
Testicular Cancer
•
NCI-CCC Tumor Board Question
•
AYA
•
Johns Hopkins
•
NCI-CCC GU Tumor Board Question
Do you treat stage 1 non-seminoma differently if there is a component of embryonal carcinoma?
Answer from: Medical Oncologist at Academic Institution
No.
Sign in or Register to read more
12828
Related Questions
In a patient with stage 1 mixed germ cell tumor who cleared tumor markers post-orchiectomy but with subsequent rise to borderline abnormal within 6 weeks, would you treat with 3 cycles BEP as for S1 disease?
For high-volume metastatic CRPC to bone, what dosing schedule of zoledronic acid or denosumab do you use?
How would you treat a patient with history of stage I seminoma s/p orchiectomy with enlarging periaortic node and normal tumor markers on surveillance?
For a young male with Stage III intermediate risk NSGCT with active 1 ppd smoking history but normal PFTs and DLCO results, would you still consider use of BEP x 4?
How do you approach therapy for a patient with stage IIIA NSGCT who received 4 cycles of EP followed by RPLND which revealed residual mixed teratoma and embryonal carcinoma?
How would you treat a patient with metastatic RCC who developed posterior reversible encephalopathy syndrome (PRES) on a TKI-containing regimen?
Do you treat de novo metastatic hormone sensitive prostate cancer presenting with a paraneoplastic syndrome more aggressively?
Do you routinely check Pulmonary function testing prior to each cycle of BEP for young patients with testicular cancer with no pulmonary risk factors?
For metastatic prostate cancer, when would you add carboplatin to docetaxel or cabazitaxel?
How does urinary obstruction impact your choice of therapy for metastatic or locally advanced prostate cancer?